OALib Journal期刊
ISSN: 2333-9721
费用:99美元
|
|
|
eif4e在非小细胞肺癌耐药性中的作用
Keywords: 非小细胞肺癌,eif4e,厄洛替尼,耐药性,egfr
Abstract:
探讨eif4e对厄洛替尼耐药细胞株细胞增殖的影响及作用机制.在配对的厄洛替尼敏感和耐药细胞株(hcc827-ep、hcc827-er)上,采用实时定量pcr检测mrna水平的变化,westernblot检测蛋白水平的变化;通过srb检测细胞的生长和药物的抑制率的变化.以及用脂质体转染eif4e的小干扰rna,用上述方法检测多种信号分子mrna、蛋白水平的变化,及对细胞生长和对药物抑制率的影响.结果显示,与hcc827-ep相比,eif4e在hcc827-er上高表达;hcc827
References
[1] | cappuzzof,ciuleanut,stelmakhl,etal.erlotinibasmaintenancetreatmentinadvancednon-small-celllungcancer:amul-ticentre,randomised,placebo-controlledphase3study[j].thelancetoncology,2010,11(6):521-529.
|
[2] | goodfellowig,robertslo.eukaryoticinitiationfactor4e[j].theinternationaljournalofbiochemistryandcellbiology,2008,40(12):2675-2680.
|
[3] | debenedettia,graffjr.eif-4eexpressionanditsroleinmalignanciesandmetastases[j].oncogene,2004,23(18):3189-3199.
|
[4] | graffjr,konicekbw,carterjh,etal.targetingtheeukaryotictranslationinitiationfactor4eforcancertherapy[j].cancerresearch,2008,68(3):631-634.
|
[5] | thummasc,kratzkera.translationalcontrol:atargetforcancertherapy[j].cancerletters,2007,258(1):1-8.
|
[6] | maz,zhul,luox,etal.perifosineenhancesmtorc1-targetedcancertherapybyactivationofgsk3βinnsclccells[j].cancerbiologyandtherapy,2012,13(11):1009-1017.
|
[7] | mathisjm,williansbj,sibleyda,etal.cancer-specifictargetingofanadenovirus-deliveredherpessimplexvirusthymidinekinasesuicidegeneusingtranslationalcontrol[j].thejournalofgenemedicine,2006,8(9):1105-1120.
|
[8] | nowakde,tianb,jamaluddinm,etal.relaser276phosphorylationisrequiredforactivationofasubsetofnf-κb-dependentgenesbyrecruitingcyclin-dependentkinase9/cyclint1complexes[j].molecularandcellularbiology,2008,28(11):3623-3638.
|
[9] | zhoubbs,peytonm,heb,etal.targetingadam-mediatedligandcleavagetoinhibither3andegfrpathwaysinnon-smallcelllungcancer[j].cancercell,2006,10(1):39-50.
|
[10] | paow,millerva,politika,etal.acquiredresistanceoflungadenocarcinomastogefitiniborerlotinibisassociatedwithasecondmutationintheegfrkinasedomain[j].plosmedicine,2005,2(3):e73.
|
[11] | cheng,kronenbergerp,teugelse,etal.effectofsirnastargetingtheegfrt790mmutationinanon-smallcelllungcancercelllineresistanttoegfrtyrosinekinaseinhibitorsandcombinationwithvariousagents[j].biochemicalandbiophysicalresearchcommunications,2013,431(3):623-629.
|
[12] | maheswarans,sequistlv,nagraths,etal.detectionofmutationsinegfrincirculatinglung-cancercells[j].newenglandjournalofmedicine,2008,359(4):366-377.
|
[13] | kobayashis,boggontj,dayaramt,etal.egfrmutationandresistanceofnon-small-celllungcancertogefitinib[j].newenglandjournalofmedicine,2005,352(8):786-792.
|
[14] | rosenwaldib.theroleoftranslationinneoplastictransformationfromapathologist爷spointofview[j].oncogene,2004,23(18):3230-3247.
|
[15] | coquereto.linkingcyclinstotranscriptionalcontrol[j].gene,2002,299(1):35-55.
|
[16] | inabat,matsushimeh,valentinem,etal.genomicorganization,chromosomallocalization,andindependentexpressionofhumancyclindgenes[j].genomics,1992,13(3):565-574.
|
[17] | jemala,siegelr,warde,etal.cancerstatistics,2008[j].ca:acancerjournalforclinicians,2008,58(2):71-96.
|
[18] | ferlayj,shinhr,brayf,etal.estimatesofworldwideburdenofcancerin2008:globocan2008[j].internationaljournalofcancer,2010,127(12):2893-2917.
|
[19] | kosakat,yamakie,mogia,etal.mechanismsofresistancetoegfrtkisanddevelopmentofanewgenerationofdrugsinnon-small-celllungcancer[j/ol].biomedresearchinternational,2011:7[2011-04-11].http://dx.doi.org/10.1155/2011/165214.
|
Full-Text
|
|
Contact Us
service@oalib.com QQ:3279437679 
WhatsApp +8615387084133
|
|